Picton Mahoney Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Picton Mahoney Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,700	Closed	-$223K	–	346
2015 Q2	$223K	Sell	3,700 -1,300	-26%	-$86K	0.01%	203
2015 Q1	$388K	Buy	+5,000	New	+$288K	0.01%	186

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Picton Mahoney Asset Management's ONCE Position: Q3 2015 in Review

Picton Mahoney Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2015, closing a stake of 3,700 shares — an estimated $223K sold.

Picton Mahoney Asset Management first reported a position in ONCE in Q1 2015 and held it in 2 quarters. The position peaked at $388K in Q1 2015. 90 funds tracked by Wall St. Rank hold ONCE as of Q3 2015.

Picton Mahoney Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Picton Mahoney Asset Management sold 3,700 Spark Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $223K.
Picton Mahoney Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
Picton Mahoney Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $388K in Q1 2015.
90 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2015, filed 28 Oct 2015.